Navigation Links
New light on Cardiology

The angiotensin-converting enzyme (ACE) inhibitor ramipril, used for the treatment of hypertension, can retrieve, and may even prevent, left ventricular hypertrophy (LVH), thereby lowering the risk of stroke and myocardial infarction (MI), a new study has shown.Results from the landmark Heat Outcome Prevention Evaluation (HOPE) study showed the drug to cause reversal and prevention of LVH in a broad range of patients – those with normal or controlled blood pressure, both with and without coronary heart disease.//

The HOPE study compared the effects of the ACE inhibitor in addition to standard therapy with placebo and vitamin E in a sample of about 7,580 high-risk patients with cardiovascular disease.In the HOPE sub-study, conducted by Dr James Chadwik and colleagues from the University of Baltimore, the electrocardiograms of 6,222 patients at baseline and at the end of the 4.5 year-long study were compared for the presence, regression or development of LVH. Cardiovascular outcomes such as MI, stroke and heart failure were also evaluated.

Among 92.9 per cent of the patients, ramipril either prevented or caused gradual regression of LVH, independent of its effect on blood pressure control. Adverse cardiovascular outcomes were also lower among those who did not develop LVH or experienced regression of their LVH, compared with those in which LVH developed or did not regress. However, 91 per cent of the patients who received a placebo experienced prevention or regression of LVH, which the researchers said was “intriguing” but was more likely to be due to other risk factor modifications among the study participants.

Since the regression of LVH found with the drug was independent of blood pressure reduction, the study authors suspect that ACE inhibitors have a direct effect in causing regression.Dr Gregory Bosen, professor of cardiovascular medicine at City Hospital in England, agrees that the research raises important issues. Dr Chadw
'"/>




Page: 1 2

Related medicine news :

1. Doctors operate upon patients in candlelight- latest from the quake scene
2. “Don’t fear long haul flights!” Vascular surgeon tells travelrs
3. Hazards of sunlight
4. Slightly High BP Poses Health Risk
5. Arterial stiffness prevented by light drinking
6. Diet, Sunlight connected to Breast Cancer Risk
7. Dangers of sunlight
8. A ray of light on Cardiology
9. Nightlights could ward diabetic blindness
10. Unborn babies respond to light
11. Sensitive to bright light? You may have sensitive teeth also
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New light Cardiology

(Date:5/24/2013)... The news about youth and diabetes keeps getting worse. ... that children who develop Type 2 diabetes are at high ... at a higher rate than people who acquire Type 2 ... 2 diabetes, they seem to be at very high risk ... M.D., professor of pediatric endocrinology in the School of Medicine ...
(Date:5/24/2013)... 2013 Fit Yummy Mummy, a fitness ... who are trying to get rid of the belly ... ideal for women who want to combine exercises with ... ’s Stan Stevenson, prompting an investigative review. , “Holly's ... a wide variety of motivational strategies, nutritional plans, proper ...
(Date:5/24/2013)... The Institute for Integrative Nutrition , the ... has donated $10,000 to the Cleveland Courage Fund , ... Ohio. , “When the news came out on Monday, May ... and her daughter had escaped from a Cleveland home after ... horrified,” said Integrative Nutrition Founder, Director, and Primary Teacher Joshua ...
(Date:5/24/2013)... 2013 General Data Company Inc., ... tracking and data management products and solutions, has ... Inc., (TBS) of Durham, North Carolina, a leading ... for the clinical and research pathology marketplace. TBS ... which provides specialty products and solutions to hospitals, ...
(Date:5/24/2013)... Finding the answer for this is at the centre of ... the Bergen fMRI Group at the University of Bergen (UiB) ... The way they do this is by studying people who ... mental illness. For a five-year period, the group is studying ... report published in Frontiers in Human Neuroscience shows ...
Breaking Medicine News(10 mins):Health News:Youth with type 2 diabetes at much higher risk for heart, kidney disease 2Health News:Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released 2Health News:Integrative Nutrition Donates $10,000 to the Cleveland Courage Fund 2Health News:General Data Acquires Triangle Biomedical Sciences 2Health News:General Data Acquires Triangle Biomedical Sciences 3Health News:Help at hand for schizophrenics 2
... the 13th time, more than any hospital in the U.S. , ... ... (NorthShore) was named one of the nation,s 100 Top Hospitals® by Thomson ... and quality of healthcare. NorthShore has been named a Top 100 Hospital ...
... (April 1, 2009) It appears that a drug ... similar effect on the compulsive behavior of kleptomaniacs it ... the University of Minnesota., The Medical School,s Department of Psychiatry ... ages 17-75, who spent an average of at least one ...
... KUALA LUMPUR, Malaysia, March 31 Rheumatoid arthritis (RA) ... which the body,s defense system attacks the joints through ... lines and lubricates the joints. The most visible symptoms ... of the hands and feet. It can cause fatigue, ...
... LifeCare Holdings, Inc. (the "Company") today announced its operating ... 2008. Three Months Ended December 31, 2008 ... service revenue of $94.2 million for the three months ended ... the same period in 2007 while patient days were unchanged. ...
... Guideline Reached For Quantitative Polymerase Chain ReactionSALT LAKE CITY, ... and the American Association for Clinical Chemistry ... for a key laboratory method called qPCR (or quantitative ... international scientists representing the medical and research fields. qPCR ...
... The U.S. District Court for the District of ... between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. ... markets CONCERTA(R) (methylphenidate HCI) Extended-Release Tablets CII, said the ... valid or infringed by the filing of Andrx,s Abbreviated ...
Cached Medicine News:Health News:NorthShore University HealthSystem Named One of the Nation's Top 100 Hospitals by Thomson Reuters 2Health News:NorthShore University HealthSystem Named One of the Nation's Top 100 Hospitals by Thomson Reuters 3Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 2Health News:Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia 3Health News:LifeCare Holdings, Inc. Announces Year-End Results 2Health News:LifeCare Holdings, Inc. Announces Year-End Results 3Health News:LifeCare Holdings, Inc. Announces Year-End Results 4Health News:LifeCare Holdings, Inc. Announces Year-End Results 5Health News:LifeCare Holdings, Inc. Announces Year-End Results 6Health News:LifeCare Holdings, Inc. Announces Year-End Results 7Health News:LifeCare Holdings, Inc. Announces Year-End Results 8Health News:LifeCare Holdings, Inc. Announces Year-End Results 9Health News:LifeCare Holdings, Inc. Announces Year-End Results 10Health News:LifeCare Holdings, Inc. Announces Year-End Results 11Health News:LifeCare Holdings, Inc. Announces Year-End Results 12Health News:LifeCare Holdings, Inc. Announces Year-End Results 13Health News:LifeCare Holdings, Inc. Announces Year-End Results 14Health News:LifeCare Holdings, Inc. Announces Year-End Results 15Health News:International Scientists Secure Quality in Molecular Diagnostics 2Health News:International Scientists Secure Quality in Molecular Diagnostics 3Health News:District Court Decision Received in CONCERTA(R) Patent Case 2Health News:District Court Decision Received in CONCERTA(R) Patent Case 3
(Date:5/24/2013)... LOS ANGELES , May 24, 2013  An ... gathered on Saturday, May 18, in Santa ... findings on new lung-sparing therapies for MPM, a rare ... and commonly affects the pleura, the lining of the ... Heart, Lung and Blood Institute, the 3rd Annual International ...
(Date:5/24/2013)... May 24, 2013 In accordance with Rule 17.1 ... 14e-1 of the United States Exchange Act, Echo Pharma Acquisition ... for Elan Corporation (NYSE: ELN). Background ... made an offer for the entire of the issued and ... (the "Original Offer").  On 20 May 2013, ...
(Date:5/23/2013)... 24, 2013 3SBio Inc. (NASDAQ: ... leading China -based biotechnology company ... products, announced today that, at an extraordinary general ... voted in favor of the proposal to authorize ... of merger dated February 8, 2013, among Decade ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 93SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... 16, 2011 Cancer patients in China ... the announcement that a leading cancer center is acquiring ... VAR). This device is the first high dose rate ... leader in radiotherapy systems. Jilin University ...
... 16, 2011 U L ... announced today that it has filed an abbreviated 510(k) application ... label claim to include the management and mitigation of pain. ... a randomized clinical study comparing Altrazeal® to Acquacel® Ag in ...
Cached Medicine Technology:First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital 2ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 2ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 3ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 4
... Detection Of Serum C-Peptide ... Measurement:, Evaluating patients ... Assisting in the classification ... Differentiating insulin dependent patients ...
Inquire...
The Pach IV is the premier product for cornea thickness measurement in conjunction with Glaucoma screening....
Inquire...
Medicine Products: